Počet záznamů: 1  

Mitochondrial complex II, a novel target for anti-cancer agents

  1. 1.
    SYSNO ASEP0420969
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevMitochondrial complex II, a novel target for anti-cancer agents
    Tvůrce(i) Klučková, Katarína (BTO-N) RID
    Bezawork-Geleta, A. (AU)
    Rohlena, Jakub (BTO-N) RID, ORCID
    Dong, L. (AU)
    Neužil, Jiří (BTO-N) RID
    Zdroj.dok.Biochimica Et Biophysica Acta-Bioenergetics. - : Elsevier - ISSN 0005-2728
    Roč. 1827, č. 5 (2013), s. 552-564
    Poč.str.13 s.
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovaMitochondrion ; Complex II ; Anti-cancer agent
    Vědní obor RIVEB - Genetika a molekulární biologie
    CEPGAP301/10/1937 GA ČR - Grantová agentura ČR
    GAP301/12/1851 GA ČR - Grantová agentura ČR
    CEZAV0Z50520701 - BTO-N (2007-2013)
    UT WOS000317795100003
    DOI10.1016/j.bbabio.2012.10.015
    AnotaceWith the arrival of the third millennium, in spite of unprecedented progress in molecular medicine, cancer remains as untamed as ever. The complexity of tumours, dictating the potential response of cancer cells to anti-cancer agents, has been recently highlighted in a landmark paper by Weinberg and Hanahan on hallmarks of cancer [1]. Together with the recently published papers on the complexity of tumours in patients and even within the same tumour (see below), the cure for this pathology seems to be an elusive goal. Indisputably, the strategy ought to be changed, searching for targets that are generally invariant across the landscape of neoplastic diseases. One such target appears to be the mitochondrial complex II (CII) of the electron transfer chain, a recent focus of research. We document and highlight this particularly intriguing target in this review paper and give examples of drugs that use CII as their molecular target. This article is part of a Special Issue entitled: Respiratory complex II: Role in cellular physiology and disease. (C) 2012 Elsevier B.V. All rights reserved.
    PracovištěBiotechnologický ústav
    KontaktMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Rok sběru2014
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.